Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$212K Buy
586
+14
+2% +$4.79K 0.05% 279
2026
Q1
$201K Buy
+572
New +$204K 0.04% 281
2025
Q2
Sell
-828
Closed -$258K 245
2025
Q1
$258K Buy
+828
New +$245K 0.07% 170
2024
Q4
Sell
-717
Closed -$231K 214
2024
Q3
$231K Buy
+717
New +$235K 0.08% 174

Other funds holding AMGN

Fielder Capital Group's AMGN Position: Q2 2026 in Review

Fielder Capital Group increased its Amgen (AMGN) stake by 2.4% in Q2 2026, buying an estimated $4.79K and bringing the position to 586 shares worth $212K. The position accounts for 0.05% of the portfolio, ranked #279.

Fielder Capital Group first reported a position in AMGN in Q3 2024 and has held it in 4 quarters since. The position peaked at $258K in Q1 2025. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Fielder Capital Group held 586 shares of Amgen worth $212K as of Q2 2026.
  • Fielder Capital Group bought 14 Amgen shares in Q2 2026, an estimated $4.79K.
  • Amgen made up 0.05% of Fielder Capital Group's portfolio in Q2 2026, its #279 holding.
  • Fielder Capital Group first reported a position in Amgen in Q3 2024 and has held it in 4 quarters since.
  • Fielder Capital Group's Amgen position peaked at $258K in Q1 2025.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Fielder Capital Group's 13F filing for Q2 2026, filed 6 Aug 2026.